Clinical Trials
31
Active:0
Completed:5
Trial Phases
6 Phases
Early Phase 1:1
Phase 1:16
Phase 2:5
+3 more phases
Drug Approvals
9
PHILIPPINES:9
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (30 trials with phase data)• Click on a phase to view related trials
Phase 1
16 (53.3%)Phase 2
5 (16.7%)Phase 3
4 (13.3%)Not Applicable
2 (6.7%)Phase 4
2 (6.7%)Early Phase 1
1 (3.3%)Safety, Tolerability, PK and PD of SSS55 in Healthy Subjects
Not Applicable
Not yet recruiting
- Conditions
- Safety Issues
- Interventions
- Drug: SSS55
- First Posted Date
- 2025-07-10
- Last Posted Date
- 2025-07-10
- Lead Sponsor
- Shenyang Sunshine Pharmaceutical Co., LTD.
- Target Recruit Count
- 26
- Registration Number
- NCT07058779
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SSS39 Injection in Healthy Chinese Subjects
- First Posted Date
- 2025-07-10
- Last Posted Date
- 2025-07-10
- Lead Sponsor
- Shenyang Sunshine Pharmaceutical Co., LTD.
- Target Recruit Count
- 48
- Registration Number
- NCT07057726
- Locations
- 🇨🇳
SSS39, Beijing, China
A Phase I Study of SPGL008 in Subjects With Advanced Malignant Tumors
Phase 1
Not yet recruiting
- Conditions
- Advanced Malignant Tumors
- Interventions
- Drug: SPGL008
- First Posted Date
- 2025-06-26
- Last Posted Date
- 2025-06-26
- Lead Sponsor
- Shenyang Sunshine Pharmaceutical Co., LTD.
- Target Recruit Count
- 96
- Registration Number
- NCT07038005
A Phase I Study of SSGJ-612 in Patients With Advanced Solid Tumors
- First Posted Date
- 2025-06-23
- Last Posted Date
- 2025-07-25
- Lead Sponsor
- Shenyang Sunshine Pharmaceutical Co., LTD.
- Target Recruit Count
- 30
- Registration Number
- NCT07032298
- Locations
- 🇨🇳
The First Affiliated Hospital of Henan University of Science & Technology, Luoyang, Henan, China
A Phase 1 Mass Balance Study of [¹⁴C]SSS17 in Healthy Chinese Males
Phase 1
Not yet recruiting
- Conditions
- Healthy Subjects (HS)
- Interventions
- Drug: [14C]SSS17
- First Posted Date
- 2025-06-18
- Last Posted Date
- 2025-06-25
- Lead Sponsor
- Shenyang Sunshine Pharmaceutical Co., LTD.
- Target Recruit Count
- 6
- Registration Number
- NCT07025915
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- Next
News
No news found